Desktop Site
|
28 Mar 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
Notices
|
S&P
BSE SENSEX
73,651.35
+655.04
+0.90 %
Corporate Announcement
Security Code
539523
Company
Alkem Laboratories Ltd
Exchange Received Time
11/11/2019 14:42:55
Exchange Disseminated Time
11/11/2019 14:42:58
Time Taken
00:00:03
Outcome of Board Meeting |
11/11/19 14:42
In continuation of our letter dated 18th October, 2019 and pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') the Board of Directors of the Company, at its meeting held today, i.e. 11th November, 2019, has inter alia:
1. approved the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended 30th September, 2019.
2. appointed Mr. Sarvesh Singh (DIN: 01278229) as an Additional Director and as a Whole Time Director designated as Executive Director on the Board of Directors of the Company w.e.f 11th November, 2019.
The meeting of the Board of Directors of the Company commenced at 10.30 A.M and concluded at 2.30 P.M
Attachment
<< Back
Recently Viewed